为了阐述HCV感染患者中,抗病毒治疗及其治疗后肝外表现间的关系,来自台湾中国医科大学临床医学研究所的Hsu YC等进行了一项大样本队列研究。选取29 3480位HCV感染的台湾居民,排除合并有其他疾病的患者,最终纳入2003年10月1日至2010年12月31日接受聚乙二醇干扰素联合利巴韦林治疗的12 384位患者为研究组,确诊后未接受治疗的24 768位患者作为对照组,研究组与对照组人数 To illustrate the relationship between antiviral therapy and extrahepatic findings after treatment in patients with HCV infection, a large cohort study was conducted by Hsu YC et al. From the Clinical Medical Institute of China Medical University in Taiwan. 29 3480 HCV-infected Taiwanese residents were selected to exclude patients with other diseases and finally included 12 384 patients who were treated with peginterferon plus ribavirin from October 1, 2003 to December 31, 2010 The patients were study group, 24 768 patients who did not receive treatment after diagnosis were taken as control group, the number of study group and control group